MIRM logo

Mirum Pharmaceuticals, Inc. (MIRM) Cash From Financing

Annual CFF:

$17.70M-$318.90M(-94.74%)
December 31, 2024

Summary

  • As of today, MIRM annual cash from financing is $17.70 million, with the most recent change of -$318.90 million (-94.74%) on December 31, 2024.
  • During the last 3 years, MIRM annual cash from financing has fallen by -$55.77 million (-75.91%).
  • MIRM annual cash from financing is now -94.74% below its all-time high of $336.60 million, reached on December 31, 2023.

Performance

MIRM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMIRMcash flow metrics

Quarterly CFF:

$8.69M+$2.33M(+36.63%)
June 30, 2025

Summary

  • As of today, MIRM quarterly cash from financing is $8.69 million, with the most recent change of +$2.33 million (+36.63%) on June 30, 2025.
  • Over the past year, MIRM quarterly cash from financing has increased by +$1.40 million (+19.16%).
  • MIRM quarterly cash from financing is now -95.81% below its all-time high of $207.13 million, reached on September 30, 2023.

Performance

MIRM Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMIRMcash flow metrics

TTM CFF:

$24.25M+$1.40M(+6.11%)
June 30, 2025

Summary

  • As of today, MIRM TTM cash from financing is $24.25 million, with the most recent change of +$1.40 million (+6.11%) on June 30, 2025.
  • Over the past year, MIRM TTM cash from financing has dropped by -$193.15 million (-88.85%).
  • MIRM TTM cash from financing is now -92.80% below its all-time high of $336.60 million, reached on December 31, 2023.

Performance

MIRM TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMIRMcash flow metrics

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

MIRM Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-94.7%+19.2%-88.8%
3Y3 Years-75.9%+65.6%-0.3%
5Y5 Years-86.1%+10000.0%-48.2%

MIRM Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-94.7%at low-95.8%+2740.7%-92.8%+71.5%
5Y5-Year-94.7%at low-95.8%+2740.7%-92.8%+71.5%
All-TimeAll-Time-94.7%at low-95.8%+2740.7%-92.8%>+9999.0%

MIRM Cash From Financing History

DateAnnualQuarterlyTTM
Jun 2025
-
$8.69M(+36.6%)
$24.25M(+6.1%)
Mar 2025
-
$6.36M(+19.1%)
$22.85M(+29.1%)
Dec 2024
$17.70M(-94.7%)
$5.34M(+38.2%)
$17.70M(+25.2%)
Sep 2024
-
$3.86M(-47.0%)
$14.14M(-93.5%)
Jun 2024
-
$7.29M(+505.1%)
$217.40M(-33.1%)
Mar 2024
-
$1.21M(-32.2%)
$324.82M(-3.5%)
Dec 2023
$336.60M(+208.6%)
$1.78M(-99.1%)
$336.60M(+0.6%)
Sep 2023
-
$207.13M(+80.6%)
$334.49M(+56.7%)
Jun 2023
-
$114.71M(+783.2%)
$213.43M(+105.3%)
Mar 2023
-
$12.99M(+4047.4%)
$103.97M(-4.7%)
Dec 2022
$109.09M
-$329.00K(-100.4%)
$109.09M(-0.9%)
Sep 2022
-
$86.07M(+1540.6%)
$110.03M(+352.6%)
Jun 2022
-
$5.25M(-71.0%)
$24.31M(-71.4%)
DateAnnualQuarterlyTTM
Mar 2022
-
$18.10M(+2843.7%)
$84.98M(+15.7%)
Dec 2021
$73.47M(-59.5%)
$615.00K(+78.3%)
$73.47M(-64.6%)
Sep 2021
-
$345.00K(-99.5%)
$207.36M(-0.8%)
Jun 2021
-
$65.91M(+899.6%)
$209.11M(+46.0%)
Mar 2021
-
$6.59M(-95.1%)
$143.22M(-21.0%)
Dec 2020
$181.29M(+42.5%)
$134.51M(+6317.4%)
$181.29M(+287.5%)
Sep 2020
-
$2.10M(+8284.0%)
$46.78M(-58.6%)
Jun 2020
-
$25.00K(-99.9%)
$113.10M(-34.2%)
Mar 2020
-
$44.66M(>+9900.0%)
$171.84M(+35.1%)
Dec 2019
$127.18M(+112.5%)
$0.00(-100.0%)
$127.18M(0.0%)
Sep 2019
-
$68.42M(+16.4%)
$127.18M(+116.4%)
Jun 2019
-
$58.76M(>+9900.0%)
$58.76M(>+9900.0%)
Mar 2019
-
$0.00
$0.00
Dec 2018
$59.84M
-
-

FAQ

  • What is Mirum Pharmaceuticals, Inc. annual cash from financing?
  • What is the all-time high annual cash from financing for Mirum Pharmaceuticals, Inc.?
  • What is Mirum Pharmaceuticals, Inc. annual cash from financing year-on-year change?
  • What is Mirum Pharmaceuticals, Inc. quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Mirum Pharmaceuticals, Inc.?
  • What is Mirum Pharmaceuticals, Inc. quarterly cash from financing year-on-year change?
  • What is Mirum Pharmaceuticals, Inc. TTM cash from financing?
  • What is the all-time high TTM cash from financing for Mirum Pharmaceuticals, Inc.?
  • What is Mirum Pharmaceuticals, Inc. TTM cash from financing year-on-year change?

What is Mirum Pharmaceuticals, Inc. annual cash from financing?

The current annual cash from financing of MIRM is $17.70M

What is the all-time high annual cash from financing for Mirum Pharmaceuticals, Inc.?

Mirum Pharmaceuticals, Inc. all-time high annual cash from financing is $336.60M

What is Mirum Pharmaceuticals, Inc. annual cash from financing year-on-year change?

Over the past year, MIRM annual cash from financing has changed by -$318.90M (-94.74%)

What is Mirum Pharmaceuticals, Inc. quarterly cash from financing?

The current quarterly cash from financing of MIRM is $8.69M

What is the all-time high quarterly cash from financing for Mirum Pharmaceuticals, Inc.?

Mirum Pharmaceuticals, Inc. all-time high quarterly cash from financing is $207.13M

What is Mirum Pharmaceuticals, Inc. quarterly cash from financing year-on-year change?

Over the past year, MIRM quarterly cash from financing has changed by +$1.40M (+19.16%)

What is Mirum Pharmaceuticals, Inc. TTM cash from financing?

The current TTM cash from financing of MIRM is $24.25M

What is the all-time high TTM cash from financing for Mirum Pharmaceuticals, Inc.?

Mirum Pharmaceuticals, Inc. all-time high TTM cash from financing is $336.60M

What is Mirum Pharmaceuticals, Inc. TTM cash from financing year-on-year change?

Over the past year, MIRM TTM cash from financing has changed by -$193.15M (-88.85%)
On this page